Regulation of 11β-hydroxysteroid dehydrogenase 1 and 2 by IGF-1 in mice

被引:12
|
作者
Huang, Yadong [2 ,3 ,4 ]
Li, Xingwang [1 ]
Lin, Han [1 ,4 ]
Chu, Yanhui [5 ]
Chen, Bingbing [6 ]
Lian, Qingquan [1 ]
Ge, Ren-Shan [1 ,4 ]
机构
[1] 2nd Affiliated Hosp, Wenzhou Med Coll, Wenzhou 325027, Zhejiang, Peoples R China
[2] Jinan Univ, Inst Life, Guangzhou 510632, Guangdong, Peoples R China
[3] Jinan Univ, Inst Hlth Engn, Guangzhou 510632, Guangdong, Peoples R China
[4] Populat Council, New York, NY 10065 USA
[5] Mudanjiang Med Univ, Heilongjiang Key Lab Antifibrosis Biotherapy, Mudanjiang, Heilongjiang, Peoples R China
[6] Wenzhou Med Coll, Sch Pharm, Wenzhou 325000, Zhejiang, Peoples R China
关键词
Corticosterone; 11 beta-Hydroxysteroid dehydrogenase; IGF-1; BETA-HYDROXYSTEROID DEHYDROGENASE; APPARENT MINERALOCORTICOID EXCESS; RAT LEYDIG-CELLS; GROWTH-HORMONE; GLUCOCORTICOID METABOLISM; IN-VIVO; MODULATION; EXPRESSION; CORTISONE; TYPE-1;
D O I
10.1016/j.bbrc.2009.12.148
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two isoforms of 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD1 and 11 beta-HSD2) play an important role in regulation of glucocorticoid corticosterone (CORT, the active form in rodents) by the interconversion between CORT and 11-dehydrocorticosterone (11DHC, the biologically inert form). 11 beta-HSD1 is an NADP+/NADPH-dependent oxidoreductase which is mainly expressed in liver and kidney, while 11 beta-HSD2 is an NAD+-dependent oxidase which is predominantly expressed in kidney. The regulation of 11 beta-HSD1 and 11 beta-HSD2 mRNA (Hsd11b1 and Hsd11b2) levels and their activities by IGF-1 was performed in liver, kidney, and testis of IGF-1 knockout mate mice. Real-time PCR showed that Hsd11b1 in liver was decreased while Hsd11b2 mRNA level was decreased in kidney of IGF-1 null mice. 11 beta-HSD1 and 11 beta-HSD2 activities fluctuated with the changes of their respective Hsd11b1 or Hsd11b2 mRNA levels. In conclusion, IGF-1 tissue-specifically regulates Hsd11b1 and Hsd11b2 expression. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:1752 / 1756
页数:5
相关论文
共 50 条
  • [31] IGF-1, Epigenetic Regulation and Cardiovascular Disease
    Yang, X.
    Li, Y. X.
    CARDIOLOGY, 2009, 114 : 78 - 79
  • [33] Inhibition of 11β-hydroxysteroid dehydrogenase type 1 in obesity
    Deborah J. Wake
    Brian R. Walker
    Endocrine, 2006, 29 : 101 - 108
  • [34] Characterization of neuronal IGF-1 deficient mice
    Ran, Q
    Gu, M
    Adamo, M
    Roberts, J
    Richardson, A
    GERONTOLOGIST, 2005, 45 : 63 - 63
  • [35] Discovery of 11β-hydroxysteroid dehydrogenase type 1 inhibitor
    Hong, Sung Pyo
    Nam, Ky Youb
    Shin, Young June
    Kim, Kil Won
    Ahn, Soon Kil
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (17) : 3501 - 3506
  • [36] 11β-hydroxysteroid dehydrogenase type 1 -: A role in inflammation?
    Chapman, KE
    Gilmour, JS
    Coutinho, AE
    Savill, JS
    Seckl, JR
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 248 (1-2) : 3 - 8
  • [37] Role of 11β-hydroxysteroid dehydrogenase 1 on sebocyte differentiation
    Lamy, L.
    Carrere, S.
    Pascau, J.
    Rethore, S.
    Boiteau, J.
    Fournier, J.
    Bouix-Peter, C.
    Voegel, J.
    Jomard, A.
    Aubert, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S77 - S77
  • [38] Dwarfism in Mice Lacking Collagen-binding Integrins α2β1 and α11β1 Is Caused by Severely Diminished IGF-1 Levels
    Blumbach, Katrin
    Niehoff, Anja
    Belgardt, Bengt F.
    Ehlen, Harald W. A.
    Schmitz, Markus
    Hallinger, Ralf
    Schulz, Jan-Niklas
    Bruening, Jens C.
    Krieg, Thomas
    Schubert, Markus
    Gullberg, Donald
    Eckes, Beate
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (09) : 6431 - 6440
  • [39] 11β-Hydroxysteroid Dehydrogenase 1: Translational and Therapeutic Aspects
    Gathercole, Laura L.
    Lavery, Gareth G.
    Morgan, Stuart A.
    Cooper, Mark S.
    Sinclair, Alexandra J.
    Tomlinson, Jeremy W.
    Stewart, Paul M.
    ENDOCRINE REVIEWS, 2013, 34 (04) : 525 - 555
  • [40] Selective 11β-hydroxysteroid dehydrogenase type 1 inhibitors
    Blum, A
    Maser, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R147 - R148